SAN DIEGO, Feb. 22, 2012 /PRNewswire/ -- Gen-Probe Incorporated (NASDAQ: GPRO) announced today that the Company will present at four upcoming investor conferences:

• RBC Capital Markets' Healthcare Conference in New York at 9 a.m. Eastern Time (ET) on February 28.  Please note this is a new presentation time. 
• Cowen and Company's 32nd Annual Healthcare Conference in Boston at 9:20 a.m. ET on March 6.
• The Raymond James 33rd Annual Institutional Investors Conference in Orlando at 8:05 a.m. ET on March 7.
• Barclays Capital's Global Healthcare Conference in Miami at 11:15 a.m. ET on March 14.

The presentations will be webcast live and may be accessed through a link on the investors section of Gen-Probe's website at www.gen-probe.com.  The webcasts will be available for 30 days following the events.

About Gen-Probe

Gen-Probe is a global leader in the development, manufacture and marketing of rapid, accurate and cost-effective molecular diagnostic products and services that are used primarily to diagnose human diseases, screen donated human blood, and ensure transplant compatibility. Gen-Probe is headquartered in San Diego and employs approximately 1,400 people. For more information, go to http://www.gen-probe.com.

Caution Regarding Forward-Looking Statements

Any statements in this press release about our expectations, beliefs, plans, objectives, assumptions, or future events or performance are not historical facts and are forward-looking statements.  Forward-looking statements are not guarantees of performance.  They involve known and unknown risks, uncertainties and assumptions that may cause actual results to differ materially from those expressed or implied.  For information about risks and uncertainties we face and a discussion of our financial statements and footnotes, see documents we have filed with the SEC, including our most recent Form 10-K, and all subsequent periodic filings.  We assume no obligation and expressly disclaim any duty to update any forward-looking statement to reflect events or circumstances after the date of this press release or to reflect the occurrence of unanticipated events.

Contact:

Paula Izidoro
Investor Relations
858-410-8904

SOURCE Gen-Probe Incorporated

Back to top

RELATED LINKS
http://www.gen-probe.com